NHU(SZ:002001) Shanxi Securities·2025-04-17 11:01Investment Rating - The report maintains a "Buy-B" rating for the company [1] Core Views - The company has shown significant growth in its performance, with a revenue increase of 42.95% year-on-year to 21.61 billion yuan in 2024, and a net profit increase of 117.01% to 5.87 billion yuan [4][5] - The nutrition product segment has benefited from rising prices and volumes, driven by new production capacity and a recovery in the downstream aquaculture industry [5] - The company has effectively managed costs through innovation and optimization of production processes, contributing to improved operational performance [5] Financial Performance Summary - In 2024, the company achieved a gross margin of 41.78%, up 8.80 percentage points year-on-year, and a net margin of 27.29%, up 9.26 percentage points year-on-year [4] - The fourth quarter of 2024 saw a revenue of 5.83 billion yuan, a year-on-year increase of 41.99%, and a net profit of 1.88 billion yuan, a year-on-year increase of 211.60% [4] - The company forecasts a net profit of 1.8 to 1.9 billion yuan for the first quarter of 2025, representing a year-on-year growth of 107% to 118% [4] Future Projections - Revenue projections for 2025 to 2027 are 23.94 billion yuan, 26.27 billion yuan, and 28.65 billion yuan, with year-on-year growth rates of 10.8%, 9.7%, and 9.1% respectively [7] - Net profit projections for the same period are 6.32 billion yuan, 6.99 billion yuan, and 7.73 billion yuan, with year-on-year growth rates of 7.6%, 10.7%, and 10.6% respectively [7] - The report indicates an expected EPS of 2.06 yuan, 2.27 yuan, and 2.52 yuan for 2025, 2026, and 2027 respectively, with corresponding P/E ratios of 10.8, 9.8, and 8.8 [7]